Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 312

1.

Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes.

Carandini T, Arighi A, Sacchi L, Fumagalli GG, Pietroboni AM, Ghezzi L, Colombi A, Scarioni M, Fenoglio C, De Riz MA, Marotta G, Scarpini E, Galimberti D.

Alzheimers Res Ther. 2019 Oct 15;11(1):84. doi: 10.1186/s13195-019-0543-7.

2.

Comparing Free Play and Partly Structured Play in 4-5-Years-Old Children in an Outdoor Playground.

Tortella P, Haga M, Ingebrigtsen JE, Fumagalli GF, Sigmundsson H.

Front Public Health. 2019 Jul 16;7:197. doi: 10.3389/fpubh.2019.00197. eCollection 2019.

3.

Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?

Arighi A, Di Cristofori A, Fenoglio C, Borsa S, D'Anca M, Fumagalli GG, Locatelli M, Carrabba G, Pietroboni AM, Ghezzi L, Carandini T, Colombi A, Scarioni M, De Riz MA, Serpente M, Rampini PM, Scarpini E, Galimberti D.

J Alzheimers Dis. 2019;69(3):663-669. doi: 10.3233/JAD-190119.

PMID:
31156164
4.

Self-assembling Releasable Thiocolchicine-Diphenylbutenylaniline Conjugates.

Fumagalli G, Polito L, Colombo E, Foschi F, Christodoulou MS, Galeotti F, Perdicchia D, Bassanini I, Riva S, Seneci P, García-Argáez A, Dalla Via L, Passarella D.

ACS Med Chem Lett. 2019 Jan 4;10(4):611-614. doi: 10.1021/acsmedchemlett.8b00605. eCollection 2019 Apr 11.

PMID:
30996805
5.

The forearm arteriovenous graft between the brachial artery and the brachial vein as a reliable dialysis vascular access for patients with inadequate superficial veins.

Fumagalli G, Trovato F, Migliori M, Panichi V, De Pietro S.

J Vasc Surg. 2019 Jul;70(1):199-207.e4. doi: 10.1016/j.jvs.2018.10.101. Epub 2019 Mar 17.

PMID:
30894304
6.

Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease.

Galimberti D, Fenoglio C, Ghezzi L, Serpente M, Arcaro M, D'Anca M, De Riz M, Arighi A, Fumagalli GG, Pietroboni AM, Piccio L, Scarpini E.

Cytokine. 2019 Apr;116:115-119. doi: 10.1016/j.cyto.2018.12.024. Epub 2019 Jan 25.

PMID:
30690291
7.

Monozygotic Twins with Frontotemporal Dementia Due To Thr272fs GRN Mutation Discordant for Age At Onset.

Fumagalli GG, Sacchi L, Basilico P, Arighi A, Carandini T, Scarioni M, Colombi A, Pietroboni A, Ghezzi L, Fenoglio C, Serpente M, D'anca M, Arcaro M, Mercurio M, Triulzi F, Scola E, Marotta G, Scarpini E, Galimberti D.

J Alzheimers Dis. 2019;67(4):1173-1179. doi: 10.3233/JAD-180723.

PMID:
30689572
8.

Behavioral and Neurophysiological Effects of Transcranial Direct Current Stimulation (tDCS) in Fronto-Temporal Dementia.

Ferrucci R, Mrakic-Sposta S, Gardini S, Ruggiero F, Vergari M, Mameli F, Arighi A, Spallazzi M, Barocco F, Michelini G, Pietroboni AM, Ghezzi L, Fumagalli GG, D'Urso G, Caffarra P, Scarpini E, Priori A, Marceglia S.

Front Behav Neurosci. 2018 Oct 29;12:235. doi: 10.3389/fnbeh.2018.00235. eCollection 2018.

9.

Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.

Pietroboni AM, Carandini T, Colombi A, Mercurio M, Ghezzi L, Giulietti G, Scarioni M, Arighi A, Fenoglio C, De Riz MA, Fumagalli GG, Basilico P, Serpente M, Bozzali M, Scarpini E, Galimberti D, Marotta G.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):280-287. doi: 10.1007/s00259-018-4182-1. Epub 2018 Oct 21.

PMID:
30343433
10.

Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models.

Chiorazzi A, Wozniak KM, Rais R, Wu Y, Gadiano AJ, Farah MH, Liu Y, Canta A, Alberti P, Rodriguez-Menendez V, Meregalli C, Fumagalli G, Monza L, Pozzi E, Vornov JJ, Polydefkis M, Pietra C, Slusher BS, Cavaletti G.

Eur J Pharmacol. 2018 Dec 5;840:89-103. doi: 10.1016/j.ejphar.2018.09.029. Epub 2018 Sep 27.

PMID:
30268665
11.

High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats.

Meregalli C, Marjanovic I, Scali C, Monza L, Spinoni N, Galliani C, Brivio R, Chiorazzi A, Ballarini E, Rodriguez-Menendez V, Carozzi VA, Alberti P, Fumagalli G, Pozzi E, Canta A, Quartu M, Briani C, Oggioni N, Marmiroli P, Cavaletti G.

J Neuroinflammation. 2018 Aug 21;15(1):232. doi: 10.1186/s12974-018-1270-x.

12.

CSF β-amyloid predicts prognosis in patients with multiple sclerosis.

Pietroboni AM, Caprioli M, Carandini T, Scarioni M, Ghezzi L, Arighi A, Cioffi S, Cinnante C, Fenoglio C, Oldoni E, De Riz MA, Basilico P, Fumagalli GG, Colombi A, Giulietti G, Serra L, Triulzi F, Bozzali M, Scarpini E, Galimberti D.

Mult Scler. 2019 Aug;25(9):1223-1231. doi: 10.1177/1352458518791709. Epub 2018 Aug 7.

PMID:
30084711
13.

Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy.

Meregalli C, Fumagalli G, Alberti P, Canta A, Carozzi VA, Chiorazzi A, Monza L, Pozzi E, Sandelius Å, Blennow K, Zetterberg H, Marmiroli P, Cavaletti G.

Exp Neurol. 2018 Sep;307:129-132. doi: 10.1016/j.expneurol.2018.06.005. Epub 2018 Jun 13.

PMID:
29908147
14.

Heteronanoparticles by Self-Assembly of Ecdysteroid and Doxorubicin Conjugates To Overcome Cancer Resistance.

Fumagalli G, Giorgi G, Vágvölgyi M, Colombo E, Christodoulou MS, Collico V, Prosperi D, Dosio F, Hunyadi A, Montopoli M, Hyeraci M, Silvani A, Lesma G, Via LD, Passarella D.

ACS Med Chem Lett. 2018 Apr 17;9(5):468-471. doi: 10.1021/acsmedchemlett.8b00078. eCollection 2018 May 10.

15.

Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales.

Fumagalli GG, Basilico P, Arighi A, Bocchetta M, Dick KM, Cash DM, Harding S, Mercurio M, Fenoglio C, Pietroboni AM, Ghezzi L, van Swieten J, Borroni B, de Mendonça A, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, Sorbi S, Scarpini E, Rohrer JD, Galimberti D; Genetic FTD Initiative (GENFI).

Alzheimers Res Ther. 2018 May 24;10(1):46. doi: 10.1186/s13195-018-0376-9.

16.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

17.

Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients.

Serpente M, Fenoglio C, Cioffi SMG, Oldoni E, Arcaro M, Arighi A, Fumagalli GG, Ghezzi L, Scarpini E, Galimberti D.

J Alzheimers Dis. 2018;61(4):1289-1294. doi: 10.3233/JAD-170861.

PMID:
29376874
18.

Alzheimer's Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian Cohort of Geriatric Outpatients: A Retrospective Cross-sectional Study.

Dolci GAM, Damanti S, Scortichini V, Galli A, Rossi PD, Abbate C, Arosio B, Mari D, Arighi A, Fumagalli GG, Scarpini E, Inglese S, Marcucci M.

Front Med (Lausanne). 2017 Nov 22;4:203. doi: 10.3389/fmed.2017.00203. eCollection 2017.

19.

Molecular simulations of cellular processes.

Trovato F, Fumagalli G.

Biophys Rev. 2017 Dec;9(6):941-958. doi: 10.1007/s12551-017-0363-6. Epub 2017 Nov 28. Review.

20.

Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine.

Fattore L, Piva A, Zanda MT, Fumagalli G, Chiamulera C.

Psychopharmacology (Berl). 2018 Feb;235(2):433-445. doi: 10.1007/s00213-017-4793-4. Epub 2017 Nov 25. Review.

PMID:
29178010
21.

Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study.

Galimberti D, Fumagalli GG, Fenoglio C, Cioffi SMG, Arighi A, Serpente M, Borroni B, Padovani A, Tagliavini F, Masellis M, Tartaglia MC, van Swieten J, Meeter L, Graff C, de Mendonça A, Bocchetta M, Rohrer JD, Scarpini E; Genetic FTD Initiative (GENFI).

Neurobiol Aging. 2018 Feb;62:245.e9-245.e12. doi: 10.1016/j.neurobiolaging.2017.10.016. Epub 2017 Nov 13.

22.

Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation.

Ghezzi L, Carandini T, Arighi A, Fenoglio C, Arcaro M, De Riz M, Pietroboni AM, Fumagalli GG, Basilico P, Calvi A, Scarioni M, Colombi A, Serpente M, Marotta G, Benti R, Scarpini E, Galimberti D.

Neurology. 2017 Dec 12;89(24):2503-2505. doi: 10.1212/WNL.0000000000004747. Epub 2017 Nov 15. No abstract available.

PMID:
29142083
23.

Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference?

Arighi A, Carandini T, Mercurio M, Carpani G, Pietroboni AM, Fumagalli G, Ghezzi L, Basilico P, Calvi A, Scarioni M, De Riz M, Fenoglio C, Scola E, Triulzi F, Galimberti D, Scarpini E.

J Alzheimers Dis. 2018;61(1):47-52. doi: 10.3233/JAD-170712.

PMID:
29125489
24.

The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients.

Pietroboni AM, Dell'Arti L, Caprioli M, Scarioni M, Carandini T, Arighi A, Ghezzi L, Fumagalli GG, De Riz MA, Basilico P, Colombi A, Benatti E, Triulzi F, Scarpini E, Viola F, Galimberti D.

Mult Scler. 2019 Jan;25(1):31-38. doi: 10.1177/1352458517740214. Epub 2017 Nov 10.

25.

High Yield of Adult Oligodendrocyte Lineage Cells Obtained from Meningeal Biopsy.

Dolci S, Pino A, Berton V, Gonzalez P, Braga A, Fumagalli M, Bonfanti E, Malpeli G, Pari F, Zorzin S, Amoroso C, Moscon D, Rodriguez FJ, Fumagalli G, Bifari F, Decimo I.

Front Pharmacol. 2017 Oct 12;8:703. doi: 10.3389/fphar.2017.00703. eCollection 2017.

26.

CSF β-amyloid and white matter damage: a new perspective on Alzheimer's disease.

Pietroboni AM, Scarioni M, Carandini T, Basilico P, Cadioli M, Giulietti G, Arighi A, Caprioli M, Serra L, Sina C, Fenoglio C, Ghezzi L, Fumagalli GG, De Riz MA, Calvi A, Triulzi F, Bozzali M, Scarpini E, Galimberti D.

J Neurol Neurosurg Psychiatry. 2018 Apr;89(4):352-357. doi: 10.1136/jnnp-2017-316603. Epub 2017 Oct 20.

PMID:
29054920
27.

Amino acid supplements and metabolic health: a potential interplay between intestinal microbiota and systems control.

Bifari F, Ruocco C, Decimo I, Fumagalli G, Valerio A, Nisoli E.

Genes Nutr. 2017 Oct 4;12:27. doi: 10.1186/s12263-017-0582-2. eCollection 2017. Review.

28.

Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) Attenuates Myocardial Fibrosis in Post-heterotopic Heart Transplantation.

Ahmed N, Linardi D, Muhammad N, Chiamulera C, Fumagalli G, Biagio LS, Gebrie MA, Aslam M, Luciani GB, Faggian G, Rungatscher A.

Front Pharmacol. 2017 Sep 15;8:645. doi: 10.3389/fphar.2017.00645. eCollection 2017.

29.

Heteronanoparticles by self-Assembly of Doxorubicin and Cyclopamine Conjugates.

Fumagalli G, Stella B, Pastushenko I, Ricci F, Christodoulou MS, Damia G, Mazza D, Arpicco S, Giannini C, Morosi L, Dosio F, Sotiropoulou PA, Passarella D.

ACS Med Chem Lett. 2017 Aug 1;8(9):953-957. doi: 10.1021/acsmedchemlett.7b00262. eCollection 2017 Sep 14.

30.

Comment on "Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction".

Benini A, Fumagalli GF.

Biomed Res Int. 2017;2017:7698452. doi: 10.1155/2017/7698452. Epub 2017 Jul 18. No abstract available.

31.

New neurons in adult brain: distribution, molecular mechanisms and therapies.

Pino A, Fumagalli G, Bifari F, Decimo I.

Biochem Pharmacol. 2017 Oct 1;141:4-22. doi: 10.1016/j.bcp.2017.07.003. Epub 2017 Jul 8. Review.

PMID:
28690140
32.

The 1,2,3-triazole ring as a bioisostere in medicinal chemistry.

Bonandi E, Christodoulou MS, Fumagalli G, Perdicchia D, Rastelli G, Passarella D.

Drug Discov Today. 2017 Oct;22(10):1572-1581. doi: 10.1016/j.drudis.2017.05.014. Epub 2017 Jul 1. Review.

PMID:
28676407
33.

Enantioselective Narasaka-Heck cyclizations: synthesis of tetrasubstituted nitrogen-bearing stereocenters.

Race NJ, Faulkner A, Fumagalli G, Yamauchi T, Scott JS, Rydén-Landergren M, Sparkes HA, Bower JF.

Chem Sci. 2017 Mar 1;8(3):1981-1985. doi: 10.1039/c6sc04466b. Epub 2016 Nov 24.

34.

Correction: Self-assembled 4-(1,2-diphenylbut-1-en-1-yl)aniline based nanoparticles: podophyllotoxin and aloin as building blocks.

Fumagalli G, Christodoulou MS, Riva B, Revuelta I, Marucci C, Collico V, Prosperi D, Riva S, Perdicchia D, Bassanini I, García-Argáez A, Via LD, Passarella D.

Org Biomol Chem. 2017 Feb 21;15(7):1725. doi: 10.1039/c7ob90018j. Epub 2017 Feb 2.

PMID:
28150007
35.

Self-assembled 4-(1,2-diphenylbut-1-en-1-yl)aniline based nanoparticles: podophyllotoxin and aloin as building blocks.

Fumagalli G, Christodoulou MS, Riva B, Revuelta I, Marucci C, Collico V, Prosperi D, Riva S, Perdicchia D, Bassanini I, García-Argáez A, Via LD, Passarella D.

Org Biomol Chem. 2017 Feb 1;15(5):1106-1109. doi: 10.1039/c6ob02591a.

PMID:
28093593
36.

Recent Methodologies That Exploit C-C Single-Bond Cleavage of Strained Ring Systems by Transition Metal Complexes.

Fumagalli G, Stanton S, Bower JF.

Chem Rev. 2017 Jul 12;117(13):9404-9432. doi: 10.1021/acs.chemrev.6b00599. Epub 2017 Jan 11.

PMID:
28075115
37.

CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.

Pietroboni AM, Schiano di Cola F, Scarioni M, Fenoglio C, Spanò B, Arighi A, Cioffi SM, Oldoni E, De Riz MA, Basilico P, Calvi A, Fumagalli GG, Triulzi F, Galimberti D, Bozzali M, Scarpini E.

Mult Scler. 2017 Jul;23(8):1085-1091. doi: 10.1177/1352458516674566. Epub 2016 Oct 17.

PMID:
27754941
38.

Motor Skill Development in Italian Pre-School Children Induced by Structured Activities in a Specific Playground.

Tortella P, Haga M, Loras H, Sigmundsson H, Fumagalli G.

PLoS One. 2016 Jul 27;11(7):e0160244. doi: 10.1371/journal.pone.0160244. eCollection 2016.

39.

Self-assembly drug conjugates for anticancer treatment.

Fumagalli G, Marucci C, Christodoulou MS, Stella B, Dosio F, Passarella D.

Drug Discov Today. 2016 Aug;21(8):1321-9. doi: 10.1016/j.drudis.2016.06.018. Epub 2016 Jun 18. Review.

40.

Outcomes of Vascular Access Care and Surgery Managed by Interventional Nephrologists: A Twelve-Year Experience.

Fumagalli G, De Pietro S, Migliori M, Ferrandello FP, Trovato F, Donadio C, Panichi V.

Blood Purif. 2016;42(2):111-20. doi: 10.1159/000446274. Epub 2016 May 26.

PMID:
27222261
41.

Benzylic C-H Azidation Using the Zhdankin Reagent and a Copper Photoredox Catalyst.

Rabet PT, Fumagalli G, Boyd S, Greaney MF.

Org Lett. 2016 Apr 1;18(7):1646-9. doi: 10.1021/acs.orglett.6b00512. Epub 2016 Mar 23.

PMID:
27007454
42.

MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.

Harper L, Fumagalli GG, Barkhof F, Scheltens P, O'Brien JT, Bouwman F, Burton EJ, Rohrer JD, Fox NC, Ridgway GR, Schott JM.

Brain. 2016 Apr;139(Pt 4):1211-25. doi: 10.1093/brain/aww005. Epub 2016 Mar 1.

43.

PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.

Oldoni E, Fumagalli GG, Serpente M, Fenoglio C, Scarioni M, Arighi A, Bruno G, Talarico G, Confaloni A, Piscopo P, Nacmias B, Sorbi S, Rainero I, Rubino E, Pinessi L, Binetti G, Ghidoni R, Benussi L, Grande G, Arosio B, Bursey D, Kauwe JS, Cioffi SM, Arcaro M, Mari D, Mariani C, Scarpini E, Galimberti D.

J Alzheimers Dis. 2016;50(2):353-7. doi: 10.3233/JAD-150863.

44.

Enzymatic Kinetic Resolution of 2-Piperidineethanol for the Enantioselective Targeted and Diversity Oriented Synthesis.

Perdicchia D, Christodoulou MS, Fumagalli G, Calogero F, Marucci C, Passarella D.

Int J Mol Sci. 2015 Dec 24;17(1). pii: E17. doi: 10.3390/ijms17010017. Review.

45.

The modulation of BDNF expression and signalling dissects the antidepressant from the reinforcing properties of ketamine: Effects of single infusion vs. chronic self-administration in rats.

Caffino L, Di Chio M, Giannotti G, Venniro M, Mutti A, Padovani L, Cheung D, Fumagalli GF, Yew DT, Fumagalli F, Chiamulera C.

Pharmacol Res. 2016 Feb;104:22-30. doi: 10.1016/j.phrs.2015.12.014. Epub 2015 Dec 17.

PMID:
26706783
46.

Meninges harbor cells expressing neural precursor markers during development and adulthood.

Bifari F, Berton V, Pino A, Kusalo M, Malpeli G, Di Chio M, Bersan E, Amato E, Scarpa A, Krampera M, Fumagalli G, Decimo I.

Front Cell Neurosci. 2015 Oct 2;9:383. doi: 10.3389/fncel.2015.00383. eCollection 2015.

47.

Usefulness of Multi-Parametric MRI for the Investigation of Posterior Cortical Atrophy.

Arighi A, Rango M, Bozzali M, Pietroboni AM, Fumagalli G, Ghezzi L, Fenoglio C, Biondetti PR, Bresolin N, Galimberti D, Scarpini E.

PLoS One. 2015 Oct 19;10(10):e0140639. doi: 10.1371/journal.pone.0140639. eCollection 2015.

48.

Natural Products and Cancer Stem Cells.

Marucci C, Fumagalli G, Calogero F, Silvani A, Christodoulou MS, Martinet N, Passarella D.

Curr Pharm Des. 2015;21(38):5547-57. Review.

PMID:
26429713
49.

Eighty percent of French sport winners in Olympic, World and Europeans competitions have mutations in the hemochromatosis HFE gene.

Hermine O, Dine G, Genty V, Marquet LA, Fumagalli G, Tafflet M, Guillem F, Van Lierde F, Rousseaux-Blanchi MP, Palierne C, Lapostolle JC, Cervetti JP, Frey A, Jouven X, Noirez P, Toussaint JF.

Biochimie. 2015 Dec;119:1-5. doi: 10.1016/j.biochi.2015.09.028. Epub 2015 Sep 28.

PMID:
26416567
50.

Three-Component Azidation of Styrene-Type Double Bonds: Light-Switchable Behavior of a Copper Photoredox Catalyst.

Fumagalli G, Rabet PT, Boyd S, Greaney MF.

Angew Chem Int Ed Engl. 2015 Sep 21;54(39):11481-4. doi: 10.1002/anie.201502980. Epub 2015 Jun 26.

Supplemental Content

Loading ...
Support Center